title: Progestins and the endometrium in patients receiving tamoxifen.
authors.forename: G
authors.initials: G
authors.lastname: Bertelli
authors.forename: M
authors.initials: M
authors.lastname: Venturini
authors.forename: M
authors.initials: M
authors.lastname: Bergaglio
authors.forename: C
authors.initials: C
authors.lastname: Gustavino
authors.forename: R
authors.initials: R
authors.lastname: Rosso
authors.forename: M
authors.initials: M
authors.lastname: Valenzano
mesh_terms: D001943:Breast Neoplasms / Q000188:drug therapy; D004717:Endometrium; D005260:Female; D006801:Humans; D011372:Progestins / Q000627:therapeutic use*; D013629:Tamoxifen / Q000009:adverse effects* / Q000627:therapeutic use; D014591:Uterine Diseases / Q000139:chemically induced / Q000517:prevention & control*
chemical_list: D011372:Progestins; D013629:Tamoxifen